“Families deserve answers, not censorship — we follow data wherever it leads.”
The promise
Kennedy announced new FDA-funded trials into folate pathway therapy for autism, focusing on leucovorin as potential adjunct treatment. The initiative was controversial but framed as evidence-driven science rather than ideology. Autism-advocacy groups expressed cautious optimism, noting lack of prior government funding for such trials. Studies are in early recruitment phase.





